DEC003M in Prostate Cancer

NCT07657806 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: DEC003M

Sponsor

Hangzhou DAC Biotechnology Co., Ltd.